Allelic loss at chromosome 13q12 - q13 is associated with poor prognosis in familial and sporadic breast cancer
1996

Loss of BRCA2 is Linked to Poor Outcomes in Breast Cancer

Sample size: 84 publication Evidence: high

Author Information

Author(s): J van den Berg, O Johannsson, S Hakansson, H Olsson, A Borg

Primary Institution: Department of Oncology, University Hospital, Lund, Sweden

Hypothesis

Is allelic loss at chromosome 13q12 - q13 associated with poor prognosis in breast cancer?

Conclusion

The study found that loss of heterozygosity at the BRCA2 locus is significantly correlated with poor prognosis in breast cancer.

Supporting Evidence

  • 34% of tumors showed loss of heterozygosity at the BRCA2 region.
  • 80% of rapidly proliferating tumors had LOH at BRCA2.
  • LOH at BRCA2 was significantly correlated with early recurrence and death.

Takeaway

If a part of the DNA that helps prevent cancer is missing, it can make the cancer worse and lead to more serious problems.

Methodology

The study analyzed loss of heterozygosity in 84 primary breast cancer tumors using microsatellite markers.

Limitations

The study does not provide conclusive evidence that BRCA2 is the sole target for deletions at 13q12-ql3 in breast tumors.

Participant Demographics

Patients aged 26-80 years, categorized into hereditary, familial, and sporadic breast cancer.

Statistical Information

P-Value

0.001

Confidence Interval

1.3-13

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication